Renowned Pioneers in Ophthalmology Join SparingVision's Scientific Advisory Board
Renowned Pioneers in Ophthalmology Join SparingVision's Scientific Advisory Board Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board Paris, January 29, 2021 - SparingVision (the "Company"), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the strengthening of its Scientific Advisory Board ("SAB") with the appointment of internationally renowned ophthalmology pioneers Dr. Paul A. Sieving, Professor of University of California Davis School of Medicine and the former Director of the US National Eye Insti...